Agonist at nuclear receptor Rev-ErbA1. Greatly diminishes VILI-induced lung edema, inflammatory cell infiltration and TNFalpha production in a rat lung injury model2. Suppresses atherosclerosis in a mouse model3.
* VAT and and shipping costs not included. Errors and price changes excepted